Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Revenue

In the year 2023, Sarepta Therapeutics had annual revenue of $1.24B with 33.26% growth. Revenue in the quarter ending December 31, 2023 was $396.78M with 53.54% year-over-year growth.

• Revenue (ttm): $1.24B
• Revenue Growth: +33.26%
• P/S Ratio: 9.79
• Revenue / Employee: $946,222
• Employees: 1,314
• Market Cap: 12.17B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.24B	310.32M	33.26%
Dec 31, 2022	933.01M	231.13M	32.93%
Dec 31, 2021	701.89M	161.79M	29.96%
Dec 31, 2020	540.10M	159.27M	41.82%
Dec 31, 2019	380.83M	79.80M	26.51%
Dec 31, 2018	301.03M	146.45M	94.74%
Dec 31, 2017	154.58M	149.16M	2,751.58%
Dec 31, 2016	5.42M	4.17M	332.64%
Dec 31, 2015	1.25M	-8.50M	-87.16%
Dec 31, 2014	9.76M	-4.46M	-31.38%
Dec 31, 2013	14.22M	-23.11M	-61.91%
Dec 31, 2012	37.33M	-9.66M	-20.56%
Dec 31, 2011	46.99M	17.57M	59.72%
Dec 31, 2010	29.42M	11.84M	67.30%
Dec 31, 2009	17.59M	-3.67M	-17.28%
Dec 31, 2008	21.26M	10.27M	93.52%
Dec 31, 2007	10.99M	10.87M	9,428.06%
Dec 31, 2006	115.29K	-4.67M	-97.59%
Dec 31, 2005	4.78M	4.35M	1,011.31%
Dec 31, 2004	430.46K	-539.41K	-55.62%
Dec 31, 2003	969.87K	133.08K	15.90%
Dec 31, 2002	836.78K	130.68K	18.51%
Dec 31, 2001	706.10K	-591.24K	-45.57%
Dec 31, 2000	1.30M	1.28M	7,520.64%
Dec 31, 1999	17.02K	-103.33K	-85.85%
Dec 31, 1998	120.35K	106.01K	738.98%
Dec 31, 1997	14.35K	-12.88K	-47.31%
Dec 31, 1996	27.23K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.